All caregivers need to trust the accuracy of automated blood pressure (BP) devices they use to make clinical decisions. But when considering one specific BP device versus another, how does one establish that trust? Well, an automated BP device that’s used to guide patient treatment is legally considered a medical device, and therefore must adhere to the regulatory guidelines for the markets in which it is sold.

We’ve written quite a bit here on the SunTech blog about BP technique. And guess what? We’re going to talk about it again! Maybe it’s not the most fascinating topic in the world of non-invasive blood pressure, but I think there are few as important to the successful treatment of high blood pressure. I must not be the only one, because studies that look at blood pressure technique continue to be published at a pretty good clip.

One of the more recent ones is aptly titled, “Blood Pressure Monitoring Technique Impacts Hypertension Treatment”. Authored by Ray et al and published in the Journal of General Internal Medicine, this study compared the way that BP’s are normally taken during triage check-in on a population of 40 patients at the New Mexico Hospital Adult Internal Medicine Clinic. A study investigator observed the technique used by the clinician, and then took the patient’s BP using the AHA recommendations for blood pressure measurement published in 2005.

In a recent article for MD+DI, we were asked to provide insight on OEM partnerships and what makes them work. In the article, we explain how the developers of the iPhone used OEM partnerships to produce a market-leading product and why those partnerships work; we also detail the numerous benefits and considerations for forming an alliance, such as:

1. Reducing development time and cost.
2. Minimizing investment in manufacturing.
3. Reducing production and material costs.
4. Helping gain market and product expertise.
   *To see the full article click here

As we have discussed in previous blogs, there’s a process in deciding whether to work with an OEM technology supplier and with whom to choose to partner once you determine that outside expertise is needed.  Combining academic insight with our 20 plus years experience providing OEM blood pressure technologies to the medical device industry, this article delves into how and why we think OEM partnerships work to help create market-changing products.

Three months ago, the National Institute for Health and Clinical Excellence (NICE) in the UK released new guidelines for managing hypertension in adults. The new recommendations call for the use of Ambulatory Blood Pressure Monitoring (ABPM) to confirm a diagnosis of hypertension when a patient has a clinic BP reading of 140/90 mmHg or above. One of the major questions raised was how this would be implemented.

Healthcare Associated Infections (HAIs) are one of the hottest topics in healthcare right now. Over 2,000,000 patients in the Unites States acquire HAIs, which adds an average of 8 days to the hospital stay and causes approximately 99,000 deaths per year.⁶ The total annual cost to treat these HAIs in the United States is between $35.7 billion and $45 billion with the average in hospital cost per patient between $20,549 and $25,903.⁷ 

That’s the question I pondered while reading an article published earlier this year in the American Journal of Hypertension. In the article “Blood Pressure Measurement Method and Inter-Arm Difference: A Meta-Analysis,"* the authors reviewed studies where BP was measured in both the left and right arm of subjects. The results showed that on average, Systolic pressures differ by 5.4 mmHg between arms while Diastolic pressures showed an average inter-arm difference of 3.6 mmHg.

Here on the SunTech blog, we normally aim to provide valuable clinical information and helpful tips related to all things blood pressure. But allow me to wax philosophical for a moment, because…well, you’ll see why.

Right. So, for many of us who work in health-care or a health-care related field, there is significant meaning to be found in doing a job that can positively affect people’s well-being. It’s great to wake up every day knowing that you will indirectly or directly help to cure illnesses, heal wounds, save lives, and treat burns due to water skis on fire…wait, huh?

Hypertension is a prevalent condition globally and is quickly becoming a focus in the U.K., with particular emphasis on how to best diagnose the condition. In August, a study comparing blood pressure (BP) measurement methods, which was funded by the U.K.’s National Institute for Health and Clinical Excellence (NICE), was published on the same day that NICE announced the release of its new guidelines for hypertension management in adults.

In the study, Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study, the research found that “ambulatory monitoring is cost effective compared with further monitoring in the clinic or home for confirming the diagnosis of hypertension” for all age and gender groups considered. Specifically, ABPM provided cost savings ranging from £56 in men aged 75 years to £323 in women aged 40 years (Equivalent to $89 and $511 respectively). Additionally, it was determined that ambulatory blood pressure monitoring (ABPM) “resulted in improved health outcomes for male and female age groups older than 50.”

Being a part of the healthcare industry, we know that reducing healthcare-associated infections (HAIs), such as MRSA (Methicillinresistant Staphylococcus aureus) and C.Diff (Clostridium Difficile), continues to be a top priority for hospitals everywhere.  What is surprising though is that based on a survey conducted in July 2011, prospective patients are becoming increasingly aware of a hospital’s ability to protect their patients from HAIs and are using this information as a major factor in determining where they seek care.